Oral Coti-2 Is Effective In A Second Animal Model Of Human Pancreatic Cancer As A Single Agent And In Combination With Abraxane(R)
Links shared publicly online about this topic.
- 1,439total visits
Oral Coti-2 Is Effective In A Second Animal Model Of Human Pancreatic Cancer As A Single Agent And In Combination With Abraxane(R)
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer
Most Recently Shared on January 21, 2010 at 7:09 pm By:
Oral Coti-2 Is Effective In A Second Animal Model Of Human Pancreatic Cancer As A Single Agent And In Combination With... http://mnt.to/3wzY
Oral COTI-2 is effective in a second animal model of human pancreatic cancer | Bioscience Technology Online
biosciencetechnology.com — “( Critical Outcome Technologies Inc ) Oral COTI-2 is effective in a second animal model of human pancreatic cancer as a single agent and in combination with Abraxane. This new series of experiments adds to the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in combination with current first line therapies, as well as low toxicity in several different animal models of human cancers.” View full resource at biosciencetechnology.com
Most Recently Shared on January 21, 2010 at 12:17 am By:
Columbia Pancreas Physician Group
RT @biosciencetech: Oral COTI-2 is effective in a second animal model of human pancreatic cancer http://bit.ly/840OUe #bioscience
Advertisement
